December 18, 2017 / 9:07 PM / a year ago

FDA approves Aerie's glaucoma treatment

Dec 18 (Reuters) - Aerie Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration approved its treatment for glaucoma, Rhopressa.

The approval was given two months ahead of the expected date, the company said. (Reporting by Tamara Mathias in Bengaluru; Editing by Arun Koyyur)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below